EP3049541A2 - Verfahren zum gerben von leder mit triazinderivaten - Google Patents
Verfahren zum gerben von leder mit triazinderivatenInfo
- Publication number
- EP3049541A2 EP3049541A2 EP14790355.3A EP14790355A EP3049541A2 EP 3049541 A2 EP3049541 A2 EP 3049541A2 EP 14790355 A EP14790355 A EP 14790355A EP 3049541 A2 EP3049541 A2 EP 3049541A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- water
- skin
- tanning
- container
- collagen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 30
- 230000008569 process Effects 0.000 title claims abstract description 24
- 150000003918 triazines Chemical class 0.000 title claims abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 25
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 19
- 241001465754 Metazoa Species 0.000 claims abstract description 6
- 238000005406 washing Methods 0.000 claims abstract 3
- 102000008186 Collagen Human genes 0.000 claims description 32
- 108010035532 Collagen Proteins 0.000 claims description 32
- 229920001436 collagen Polymers 0.000 claims description 32
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 claims description 22
- BMTZEAOGFDXDAD-UHFFFAOYSA-M 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholin-4-ium;chloride Chemical compound [Cl-].COC1=NC(OC)=NC([N+]2(C)CCOCC2)=N1 BMTZEAOGFDXDAD-UHFFFAOYSA-M 0.000 claims description 19
- 239000000126 substance Substances 0.000 claims description 18
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 claims description 15
- 150000001718 carbodiimides Chemical class 0.000 claims description 6
- 238000004132 cross linking Methods 0.000 claims description 6
- 239000000835 fiber Substances 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 4
- 230000002500 effect on skin Effects 0.000 claims description 3
- 239000012190 activator Substances 0.000 claims description 2
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 claims 1
- 239000010985 leather Substances 0.000 abstract description 22
- 230000001131 transforming effect Effects 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 description 13
- 230000015572 biosynthetic process Effects 0.000 description 12
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 11
- 239000000412 dendrimer Substances 0.000 description 11
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 10
- 239000012153 distilled water Substances 0.000 description 10
- 229920000736 dendritic polymer Polymers 0.000 description 9
- 229920001864 tannin Polymers 0.000 description 9
- 239000001648 tannin Substances 0.000 description 9
- 235000018553 tannin Nutrition 0.000 description 9
- 239000000243 solution Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 150000001412 amines Chemical class 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 238000009833 condensation Methods 0.000 description 4
- 230000005494 condensation Effects 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- FIDRAVVQGKNYQK-UHFFFAOYSA-N 1,2,3,4-tetrahydrotriazine Chemical compound C1NNNC=C1 FIDRAVVQGKNYQK-UHFFFAOYSA-N 0.000 description 3
- 125000003277 amino group Chemical group 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 3
- 229910052804 chromium Inorganic materials 0.000 description 3
- 239000011651 chromium Substances 0.000 description 3
- -1 for example Chemical class 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 238000005554 pickling Methods 0.000 description 3
- 230000009257 reactivity Effects 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- SCCCIUGOOQLDGW-UHFFFAOYSA-N 1,1-dicyclohexylurea Chemical compound C1CCCCC1N(C(=O)N)C1CCCCC1 SCCCIUGOOQLDGW-UHFFFAOYSA-N 0.000 description 2
- GPIQOFWTZXXOOV-UHFFFAOYSA-N 2-chloro-4,6-dimethoxy-1,3,5-triazine Chemical compound COC1=NC(Cl)=NC(OC)=N1 GPIQOFWTZXXOOV-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 230000000711 cancerogenic effect Effects 0.000 description 2
- 231100000357 carcinogen Toxicity 0.000 description 2
- 239000003183 carcinogenic agent Substances 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 231100000433 cytotoxic Toxicity 0.000 description 2
- 230000001472 cytotoxic effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- WYNCHZVNFNFDNH-UHFFFAOYSA-N Oxazolidine Chemical compound C1COCN1 WYNCHZVNFNFDNH-UHFFFAOYSA-N 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical class [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical class [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 150000001263 acyl chlorides Chemical class 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 229910052782 aluminium Chemical class 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical class [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000005915 ammonolysis reaction Methods 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000013626 chemical specie Substances 0.000 description 1
- 150000001844 chromium Chemical class 0.000 description 1
- JOPOVCBBYLSVDA-UHFFFAOYSA-N chromium(6+) Chemical compound [Cr+6] JOPOVCBBYLSVDA-UHFFFAOYSA-N 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 210000003660 reticulum Anatomy 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002910 solid waste Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- YIEDHPBKGZGLIK-UHFFFAOYSA-L tetrakis(hydroxymethyl)phosphanium;sulfate Chemical compound [O-]S([O-])(=O)=O.OC[P+](CO)(CO)CO.OC[P+](CO)(CO)CO YIEDHPBKGZGLIK-UHFFFAOYSA-L 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C14—SKINS; HIDES; PELTS; LEATHER
- C14C—CHEMICAL TREATMENT OF HIDES, SKINS OR LEATHER, e.g. TANNING, IMPREGNATING, FINISHING; APPARATUS THEREFOR; COMPOSITIONS FOR TANNING
- C14C3/00—Tanning; Compositions for tanning
- C14C3/02—Chemical tanning
- C14C3/08—Chemical tanning by organic agents
Definitions
- the present invention relates to a process for treating high molecular weight proteins, particularly proteins deriving from the rough skin of animals, which allows to raise their hydrothermal stability and their resistance to rot, thus obtaining a tanned leather. More specifically, the invention describes a process for tanning leathers with triazine derivatives, in particular with dimetossitriazin-N-metilmorfolinio salts, such as, for example, the 4- (4 , 6-dimethoxy- 1, 3 , 5-triazin-2-il) -4 -metilmorfolinio chloride (DMTMM) .
- DTMM dimetossitriazin-N-metilmorfolinio salts
- the tanning process of leathers consists of different steps, in order to transform the animal skin, which is easily subjected to bacterial attacks, into a stable and resistant to rot material.
- the rough skin is normally renewed, calcined, shaved, de-calcined and soaked.
- the combination of said processes traditionally referred to as the "Riviera method" allows to remove unwanted substances (dirt, grease, blood, interfibrillary proteins, hyaluronic acid, etc.) from the skin and to open the dermal fibers in a controlled way.
- the only component of the skin which is useful for performing a tanning operation is the collagen, i.e. the protein constituting the fibrous reticulum of the leather.
- the de- calcined and soaked skin is normally subjected to a specific treatment before the tanning phase, in order to minimize the reactivity of the collagen-tanning agent and to support the penetration of said agent through the whole thickness of the leather.
- said treatment consists in an acidification, technically called “pickling", which is made by using an electrolyte which raises the osmotic pressure of the bath. Said effect is performed in order to remove the swelling of the skin which would otherwise occur together with the lowering of the pH below the isoelectric point of collagen (the "pickling" treatment is carried out by using the formic acid and the sulfuric acid as pH regulators and the sodium chloride as an osmotic electrolyte) .
- the leather When the leather is impregnated with tanning agent in conditions of low reactivity, it is possible to change the pH, thus obtaining the fixing of the tanning agent to the collagen matrix. It is very important that a molecule of the tanning agent has, in addition to a high affinity towards the organic substrate, also a good ability to penetrate into the fibers of the skin, in order to avoid wrinkling, over- tanning or other unwanted effects.
- chrome tanning after a suitable pickling process, the chromium salt is added and, once the tanning agent is penetrated into the leather, is the pH of the bath is raised from 2.8 up to 3.8-4.2, thus obtaining the final fixing.
- the overall duration of the tanning process depends on the type of skin to be treated up to a maximum of 20-24 hours.
- the above values may be subject to slight changes according to the particular formulation and to the characteristics of the leather to be made.
- tanning for leathers At present there are different types of tanning for leathers; however, those the types of tanning which are of most interest for industry are the following:
- the hydrothermal stability is indicated by the gelatinization temperature, Tg, which in this case easily exceeds 100 °C.
- Tg gelatinization temperature
- the leathers tanned with chrome are characterized by an intrinsic blue-gray coloration due to the presence of trivalent chromium which is incorporated in the fibers and which adversely affects the brightness of the dyes and consequently limits the range of colors .
- the tanning By using the tanning with aldehydes it is possible to obtain leathers with good performances but rather spongy, with low fullness and characterized by a yellowish color.
- the aldehydes are very rarely used as the sole tanning agent, but are suitably combined with other substances thus obtaining a mixed tanning.
- the synthetic tannins while presenting significant advantages over natural tannins, give rise to a leather characterized by both a low gelatinization temperature and a reduced dyeability.
- the tanning with synthetic tannins also requires, as well as the natural tannins, high amounts of the tanning agent; therefore, the synthetic tannins, as well as the aldehydes, are almost always employed for obtaining a mixed tanning.
- the vegetable tannins when used as first- tanning agents, give to the leather a high fullness and are used almost always for producing soles and heavy leathers .
- a common feature of the known tanning agents is to interact with the collagen of the skin/leather, so as to permanently remain inside its structure.
- the methods of tanning listed above have important critical aspects both from an environmental point of view and from a toxicologically point of view, mainly due to the disposal of waste (both solid and liquid) and to the presence of substances which are harmful to health inside the leather.
- waste both solid and liquid
- the presence of substances which are harmful to health inside the leather it is known that under certain conditions it is possible to have, in chrome-tanned leathers, a leakage of hexavalent chromium, which is a noxious and carcinogenic chemical substance.
- the chrome tanning raises a particular interest because of the excellent features that causes to the leather.
- the transformation of the collagen which is performed during the chrome tanning is due to the reaction between polynuclear complexes of trivalent chromium and carboxyl groups of the collagen chain, with the formation of chemical bonds having a partially covalent character that interconnect in a very stable way different sites of the molecules of collagen.
- a chemical substance has best tanning properties as the number of bridge covalent bonds, which are formed between adjacent chains of collagen, increases. That's why the tanning agent (or a derivative product in situ) becomes an integral part of the collagen matrix and remains embedded inside the leather at the end of the tanning reaction.
- the terminal and lateral functional groups of collagen that are usually involved in the tanning reaction may react together and form stable bonds even without the use of a tanning molecule.
- the carboxy and amino functionality of the collagen it is possible to generate a high degree of intramolecular cross-linking through the formation of amide bonds. Consequently, the search for new chemical species that stabilize the collagen may also extend to condensing agents which do not remain permanently incorporated inside the collagen matrix.
- Carbodiimides are organic molecules having basic characteristics thanks to the presence of two nitrogen atoms, which react with an acid, thus generating the O-acilisourea, i.e. an intermediate reactive substance which, by using an amine, gives the desired peptide bond through ammonolysis .
- DCC dicyclohexylcarbodiimide
- DCU N 1 -dicyclohexylurea
- the EDC/NHS system is generally employed as a co-reagent in presence of macromolecules with a high number of amine groups capable of reacting with the carboxyl groups of collagen by increasing the cross- linking degree and consequently the Tg with respect to what is obtained only by using the EDC/NHS system.
- Normally dendritic amines are used (synthetic polymers obtained by convergent or divergent reaction) , which, by reacting with the carboxyl groups of collagen, can be inserted permanently within the collagen structure by changing its properties in an irreversible way.
- the 2- chloro-4 , 6-dimethoxy-l , 3 , 5-triazine (CDMT) is employed as an alternative to carbodiimidi , thus allowing to obtain the condensation of a carboxylic acid with an amine in bland conditions and to easily recover the product.
- CDMT 2- chloro-4 , 6-dimethoxy-l , 3 , 5-triazine
- DMTMM A further advantage of the DMTMM is constituted by the possibility of being regenerated at the end of the reaction. Indeed, the final co-product of the reaction [2-hydroxy-4 , 6-dimethoxy-l, 3 , 5-triazine (DMT-OH) ] is very soluble in an aqueous phase and may be removed from the mother liquor for concentration.
- DMT-OH 2-hydroxy-4 , 6-dimethoxy-l, 3 , 5-triazine
- the DMTMM as well as the EDC/NHS, has found wide use in recent years in the medical field for the reconstruction of tissues and for the synthesis of oligonucleotides that are used in the medical field. It is important to underline that both the EDC/NHS and the DMTMM allow the condensation but they do not remain chemically bonded to the substrate at the end of the reaction.
- the solution according to the present invention which aims to treat proteins of high molecular weight so as to give a high hydrothermal stability and high resistance against the putrefaction.
- An object of the present invention is therefore to provide a process for tanning leathers with the salts of dimetossitriazin-N-metilmorfolinio and in particular with the 4- (4 , 6-dimethoxy-l, 3 , 5-triazin-2- ) -4 - metilmorfolinio chloride, which allows to obtain the previously described technical results.
- a further object of the invention is to provide a process for tanning leathers which can be performed with substantially reduced cost with respect to the known tanning methods.
- Another object of the invention is to provide a process for tanning leathers which is simple and safe and which provides for an easy standardization.
- the present invention provides for a process for tanning leathers by using the triazine derivatives according to the enclosed claim 1. It is clear the effectiveness of the process of the present invention, which allows to obtain leathers with high resistance to rot, high hydrothermal stability and excellent dyeability thanks to the characteristic white color, due to the absence of intrinsic colors.
- the method of tanning implemented according to the present invention does not have problems about the disposal of solid waste and does not use substances harmful to health in the finished product, such as carcinogens and/or cytotoxic substances.
- tanning reagent which is not retained within the collagen support, whose chemical composition remains unchanged.
- Tg 72-75°C.
- Tg 73°C.
- EXAMPLE 5 EDC/NHS WITH pH CONTROL AND DENDRIMERS.
- a piece of decalcined leather of about 100 g is placed in a drum containing 100 ml of water at room temperature.
- the system is rotated and then the DMTMM is added (at different concentrations, from 22% to 5.5%, with respect to the pelt weight); the DMTMM is dissolved in 200 ml of water. No control of pH or temperature. After 4 hours, the bath is drained and the system is washed 2 times with water. Result:
- Tg 83°C.
- a piece of decalcined leather of about 100 g is placed in a drum containing 100 ml of water at room temperature.
- the system is rotated and the pH is controlled with formic acid/ammonia in a range between 5.0 and 5.5.
- EDC and NHS are added (14% EDC and 8% NHS, with respect to the pelt weight) ; EDC and NHS are dissolved in 200 ml of water.
- the system is rotated and the pH is measured and, if necessary, is corrected at regular intervals of 30 minutes. After 4 hours the bath is drained and the system is washed 2 times with water. Result:
- Tg 84°C.
- the leather samples are then pressed and split, re- tanned and fattened according to the industrial practice .
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Treatment And Processing Of Natural Fur Or Leather (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000233A ITVI20130233A1 (it) | 2013-09-24 | 2013-09-24 | Procedimento per la concia del pellame con derivati della triazina |
PCT/IT2014/000226 WO2015044971A2 (en) | 2013-09-24 | 2014-08-27 | Process for tanning leathers with triazine derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3049541A2 true EP3049541A2 (de) | 2016-08-03 |
EP3049541B1 EP3049541B1 (de) | 2020-08-19 |
Family
ID=49486609
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP14790355.3A Active EP3049541B1 (de) | 2013-09-24 | 2014-08-27 | Verfahren zum gerben von leder mit triazinderivaten |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP3049541B1 (de) |
IT (1) | ITVI20130233A1 (de) |
WO (1) | WO2015044971A2 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITUA20164602A1 (it) * | 2016-06-22 | 2017-12-22 | Crossing S R L 31100 Treviso | “uso delle 2,4-dialo-6-sostituite-1,3,5-triazine, e loro derivati, come agenti di condensazione, reticolazione, concia, grafting e curing” . |
MA50851B1 (fr) * | 2018-02-16 | 2021-07-29 | Huntsman Adv Mat Switzerland | Procédé de tannage et de teinture simultanés de matériau fibreux contenant du collagène |
WO2020002979A1 (en) | 2018-06-28 | 2020-01-02 | Gruppo Mastrotto S.P.A. | Thermally dispersing and electrically conductive processed leather |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2599142A (en) * | 1949-08-12 | 1952-06-03 | American Cyanamid Co | Tanning and bleaching leather with a sulfoaromaticmelamine-formaldehyde resin |
AU2003205255B2 (en) * | 2002-01-25 | 2007-12-06 | Biomedical Design, Inc. | Calcification-resistant fixation |
CN101314058A (zh) * | 2007-05-28 | 2008-12-03 | 江阴奔翔生物科技有限公司 | 一种动物皮胶原本体改性的方法 |
US8679195B2 (en) * | 2009-05-14 | 2014-03-25 | Clariant Finance (Bvi) Limited | Tanning process and tanning composition |
WO2012055482A1 (en) * | 2010-10-28 | 2012-05-03 | Clariant International Ltd | Non-metal tanning process |
-
2013
- 2013-09-24 IT IT000233A patent/ITVI20130233A1/it unknown
-
2014
- 2014-08-27 EP EP14790355.3A patent/EP3049541B1/de active Active
- 2014-08-27 WO PCT/IT2014/000226 patent/WO2015044971A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2015044971A3 (en) | 2015-07-16 |
ITVI20130233A1 (it) | 2015-03-25 |
EP3049541B1 (de) | 2020-08-19 |
WO2015044971A2 (en) | 2015-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3049541B1 (de) | Verfahren zum gerben von leder mit triazinderivaten | |
Menezes et al. | Optimization of the collagen extraction from Nile tilapia skin (Oreochromis niloticus) and its hydrogel with hyaluronic acid | |
Yu et al. | Role of epigallocatechin gallate in collagen hydrogels modification based on physicochemical characterization and molecular docking | |
BR112017006653B1 (pt) | Método para tratamento de um substrato animal | |
Sendrea et al. | Non-invasive characterisation of collagen-based materials by NMR-mouse and ATR-FTIR | |
RU2520657C2 (ru) | Средство и способ дубления шкур и кож | |
EP3237390B1 (de) | Verfahren zur industriellen herstellung von 2-halo-4,6-dialkoxy-1,3,5-triazinen und verwendung davon in anwesenheit von aminen | |
JP3693491B2 (ja) | 改良された再生コラーゲン繊維及びその製造方法 | |
CA3007389C (en) | Method for producing of hyaluronidase conjugate with polyethylene piperazine derivatives and application of obtained conjugate | |
US3098693A (en) | Treatment of protein and peptide materials to form amide linkages | |
Beghetto et al. | PROCESS FOR TANNING LEATHERS WITH TRIAZINE DERIVATIVES | |
WO2000073513A1 (en) | Leather tanning | |
Matinong et al. | Collagen Extraction from Animal Skin. Biology 2022, 11, 905 | |
Lischuk et al. | Transformation of the collagen structure during beam-house processes and combined tanning | |
KR20100080840A (ko) | 가죽 제조 방법 | |
CN105255981B (zh) | 一种非变性海蜇胶原蛋白的制备方法 | |
Jelita et al. | Characterization of gelatin from scapula (Os scapula) from Aceh cattle | |
US2733977A (en) | Process of tanning with salt of ampho- | |
Low | Human hair keratin and its interaction with metal ions | |
Song et al. | Visualization of penetration and reaction of aldehyde tanning agent in leather using fluorescence technique | |
RU2386702C1 (ru) | Способ дубления шкур | |
JP2012087428A (ja) | 抗菌性羽毛及びその製造方法 | |
RU2182178C1 (ru) | Состав для дубления кожи и меха | |
Mohamed | Utilization of Chrome Shavings in the Production of Industrial Gelatin | |
CA3056759A1 (en) | Hydrolyzed collagen compositions and methods of making thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20160310 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAX | Request for extension of the european patent (deleted) | ||
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: ZANCANARO, AURORA Inventor name: POZZA, GIORGIO Inventor name: BEGHETTO, VALENTINA |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20180312 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20200306 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602014069195 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1304005 Country of ref document: AT Kind code of ref document: T Effective date: 20200915 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20200819 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201120 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201119 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201119 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201221 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1304005 Country of ref document: AT Kind code of ref document: T Effective date: 20200819 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20201219 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200831 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200827 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200831 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602014069195 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20200831 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 |
|
26N | No opposition filed |
Effective date: 20210520 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200827 Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200831 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200819 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20240621 Year of fee payment: 11 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20240702 Year of fee payment: 11 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20240701 Year of fee payment: 11 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20240702 Year of fee payment: 11 |